InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
crudeoil24 PremiumMember
11/22/19 8:34 AM
profile icon
davidsson10 Free
11/22/19 8:24 AM
profile icon
whytestocks Free
11/22/19 7:30 AM
profile icon
ADVFN_bioking Terminated
11/12/19 10:50 AM
profile icon
ADVFN_bioking Terminated
11/08/19 2:34 PM
profile icon
ADVFN_bioking Terminated
11/06/19 9:44 AM
profile icon
ADVFN_bioking Terminated
11/01/19 9:45 AM
profile icon
ADVFN_bioking Terminated
10/31/19 2:11 PM
profile icon
ADVFN_bioking Terminated
10/31/19 1:04 PM
profile icon
ADVFN_bioking Terminated
10/31/19 12:55 PM
profile icon
ADVFN_bioking Terminated
10/31/19 12:54 PM
profile icon
ADVFN_bioking Terminated
10/31/19 12:37 PM
profile icon
ADVFN_bioking Terminated
10/31/19 10:27 AM
profile icon
whytestocks Free
09/23/19 4:00 PM
profile icon
whytestocks Free
08/05/19 1:40 PM
profile icon
ClayTrader Free
06/03/19 5:35 PM
profile icon
whytestocks Free
06/03/19 9:50 AM
profile icon
wesley_ PremiumMember
06/03/19 9:43 AM
profile icon
ClayTrader Free
05/30/19 5:41 PM
profile icon
UFO PremiumMember
05/30/19 3:28 PM
profile icon
whytestocks Free
05/08/19 4:30 PM
profile icon
Klinsmann PremiumMember
03/26/19 2:51 PM
profile icon
vhgier Free
03/26/19 2:48 PM
profile icon
Klinsmann PremiumMember
03/22/19 2:26 PM
profile icon
Klinsmann PremiumMember
01/29/19 10:30 PM
profile icon
janeyH Free
01/29/19 7:50 PM
profile icon
Klinsmann PremiumMember
12/13/18 4:42 AM
profile icon
janeyH Free
12/12/18 9:53 PM
profile icon
janeyH Free
12/12/18 9:32 PM
profile icon
Klinsmann PremiumMember
11/26/18 11:04 AM
profile icon
Klinsmann PremiumMember
11/13/18 6:16 PM
profile icon
Klinsmann PremiumMember
11/13/18 5:04 PM
profile icon
ClayTrader Free
11/13/18 4:24 PM
profile icon
BoilerRoom Free
11/13/18 12:58 PM
profile icon
BoilerRoom Free
11/13/18 12:52 PM
profile icon
BoilerRoom Free
11/13/18 12:41 PM
profile icon
cjstocksup PremiumMember
11/13/18 11:29 AM
profile icon
arbytrader Free
11/13/18 11:24 AM
profile icon
Klinsmann PremiumMember
11/13/18 11:09 AM
profile icon
Triple nickle Free
11/13/18 10:57 AM
profile icon
cjstocksup PremiumMember
11/13/18 10:46 AM
profile icon
cjstocksup PremiumMember
11/13/18 10:44 AM
profile icon
Klinsmann PremiumMember
11/13/18 10:16 AM
profile icon
headsortails2066 Free
11/13/18 10:06 AM
profile icon
BoilerRoom Free
11/13/18 10:01 AM

Eyegate Pharmaceuticals Inc fka EYEG RSS Feed

Followers
26
Posters
98
Posts (Today)
0
Posts (Total)
418
Created
07/20/15
Type
Free
Moderators
EYEG=MC $12 M--P3 DATA IMMINENT --BRUTAL low float of 700k shares = Could explode quickly above $10

(EYEG) Market Cap $12 M --Cash $6 M or untill mid 2020 --Shares out 3.6 M --Float only 700k --Insider Armistice contiunes to add shares --OBG (PRK) final results imminent = A MONSTER OPP which could fly fast to $10-15 on positive results which i think is likely. STRONG BUY

Eyegate Pharma (EYEG)

Market Cap $13 Million
Cash $6 Million enough untill mid 2020
Price $3.50

Shares Out 3.6 Million


"Announced approval from the FDA to initiate its photorefractive keratectomy (“PRK”) pivotal study on June 3, 2019 and enrollment of the first patient on June 26, 2019. Topline results are expected by year-end 2019, after which the Company plans to submit the de novo application for commercialization. Topline results are expected by year-end 2019, after which the Company plans to submit the de novo application for commercialization. "

FDA IDE approval of this OBG-PRK pivotal study is a significant event as it not only represents a major step towards potential eventual U.S. marketing clearance of OBG in an initial indication (i.e. PRK) but also signals that a pivotal study (or other pathway towards label expansion) in punctate epitheliopathies (PE) is likely to quickly follow. The PE market is ~10x the size of the domestic PRK market, representing a potential multi billion-dollar opportunity for EYEG. So, while not to minimize the initial commercial prospects in PRK, news of this IDE approval may have even much more significant positive implications for EyeGate.



largest shareholders

Armistice...1.8M
Lau (Jonathan)...254.0K
From (Stephen)...67.0K
Wirostko...30.9K
Susquehanna...14.8K
Garanzini (Michael)...13.1K
Manzo (Michael P)...11.4K
The Vanguard ...10.9K
PanAgora Asset...6.4K
Chaney (Paul G)...6.1K






Board Info
Posts Today
0
Posts (Total)
418
Posters
98
Moderators
New Post